1.
|
Phase: Phase III, Phase II Type: Treatment Status: Active Age: 18 to 70 Sponsor: Other Protocol IDs: 20111220, NCT01689558
|
|
2.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other, Pharmaceutical / Industry Protocol IDs: CH-GI-023, NCT01529164
|
|
3.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 to 70 Sponsor: Other Protocol IDs: HunanPTH022, NCT01549093
|
|
4.
|
Phase: Phase II Type: Diagnostic, Treatment Status: Active Age: 18 to 70 Sponsor: Pharmaceutical / Industry Protocol IDs: sim-endo-201201, NCT01564329
|
|
5.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: ZhejaingCH-npc-02, NCT01612286
|
|
6.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 to 75 Sponsor: Other Protocol IDs: BeijingCH001, NCT01669707
|